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INTRODUCTION
Perinatal hypoxic­ischemic encephalopathy 
(HIE) is a common cause of neonatal morbid­
ity and mortality and neurological disabilities 
among survivors [1]. Each year 1.2 million neo­
nates die and about one million infants have 
permanent neurological disability caused by 
perinatal HIE [2]. The pathogenesis of perina­
tal hypoxic­ischemic brain damage is highly 
complex, and involves impaired blood­brain 
barrier permeability, energy failure, loss of cell 
ion homeostasis, acidosis, increased intracellu­
lar calcium, excitotoxicity, free radical mediated 
toxicity, growth factor deficiency or upregula­
tion and activation inflammatory cascade in 
immature brain [3]. Free radicals are highly 
reactive molecules generated predominantly 
during cellular respiration and normal metabo­
lism. Imbalance between cellular production of 
free radicals and the ability of cells to defend 
against them is referred to as oxidative stress. 
Glutathione peroxidase (GPX) is a principal 
antioxidant enzyme and protects the cells 
against intracellular radicals and peroxides 
coming from the respiratory chain or other 
metabolic pathways. A number of studies docu­
mented that HIE were associated with increased 
production of free radicals in animal models 
[4]. The direct measurement of free radicals 
in biological samples is difficult because they 
are extremely reactive and have a short half­
life. Therefore, particularly in human studies, 
indirect approaches have been used to demon­
strate free radical production during cerebral 
hypoxia­ischemia, measuring the products of 
free radical reaction with other molecules, such 
as lipids, proteins, and DNA, and the level or 
activity of antioxidant molecules. Neuron spe­
cific enolase (NSE) was originally described 
by Moore and McGregor [5] in 1965. NSE is 
intracytoplasmic glycolytic enzyme in neurons. 
Enolase has five isoenzymes. Those containing 
the gamma subunit, predominantly found in 
neurons of the central and peripheral nervous 
system are called NSE [6]. The major distinctive 
feature of NSE compared with other enolases is 
its high degree of stability.
OBjECTIvE
In this study, we assessed the role of oxida­
tive stress in perinatal hypoxic­ischemic brain 
injury. We estimated perinatal oxidative brain 
damage measuring activity of GPX in cerebro­
spinal fluid (CSF) as the indirect biomarker of 
free radical production during cerebral hypoxia­
ischemia in correlation with level of intracel­
lular enzyme NSE in CSF as a good biomarker 
of the extend of brain injury. Understanding 
the mechanisms of perinatal hypoxic­ischemic 
brain injury is essential to the design of effective 
neuroprotective interventions.
SUMMARy
Introduction The pathogenesis of perinatal hypoxic­ischemic brain damage is highly complex.
Objective The aim of this study was to assess the role of oxidative stress in hypoxic­ischemic brain 
injury and subsequent abnormal neurological outcome in infants with perinatal hypoxic­ischemic 
encephalopathy (HIE). We estimated perinatal oxidative brain damage measuring activity of glutathione 
peroxidase (GPX) in cerebrospinal fluid (CSF) as an indirect biomarker of free radical production during 
cerebral hypoxia­ischemia in correlation with the level of intracellular enzyme neuron specific enolase 
(NSE) in CSF as a biomarker of extend of brain injury.
Methods Ninety neonates (>32 GA) with perinatal HIE were enrolled prospectively. HIE was categorized 
into three stages according Sarnat and Sarnat clinical scoring system and changes seen on amplitude inte­
grated EEG. CSF for GPX analysis and NSE analysis was taken in the first 72 hours of life. Neurodevelopment 
outcome was assessed at 12 months of corrected gestational age.
Results GPX activity in CSF was in good relation with clinical stage of HIE (p<0.0001) and GA (p<0.0001) 
and significantly corresponded with subsequent neurodevelopment outcome (p<0.001). GPX activity in 
CSF showed a strong correlation with NSE levels in CSF (p<0.001) as the biomarker of extent of brain injury.
Conclusion Our results suggest that oxidative stress might be important contributing factor in perinatal 
hypoxic­ischemic brain damage, particularly in preterm neonates.
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METHODS
Our prospective study was performed from January 2007 to 
January 2009 and was approved by the Ethical Committee 
for the Medical Research of the School of Medicine, 
University of Belgrade. We studied 90 neonates (gestational 
age >32 weeks) with perinatal asphyxia who subsequently 
developed HIE admitted to the neonatal intensive care unit 
at the Institute of Gynaecology and Obstetrics, Clinical 
Centre of Serbia, Belgrade. Our Institute serves as a referral 
centre for high­risk pregnancies, with delivery numbers of 
7000­7500 per year. Written consent was obtained from 
all parents. Perinatal HIE was diagnosed if foetal distress 
(meconium staining of liquor or abnormal foetal heart 
rate), immediate neonatal depression (Apgar score <6 at 
5 minute and/or necessary intubations in delivery room), 
metabolic acidosis (pH<7.20, BE≥10 mmol/l and lactate 
>3 mmol/L on arterial cord blood within 60 minutes of 
birth) and early neonatal encephalopathy (within the first 
24 hours of life) were present. All of the neonates were 
resuscitated according to the guidelines of the Newborn 
Resuscitation Program of the American Academy of 
Pediatrics and American Heart Association. [7].
Complete obstetrical history and physical examina­
tions were obtained on admission. Perinatal HIE was cat­
egorized into three stages according to Sarnat and Sarnat 
clinical scoring system and changes seen on amplitude 
integrated EEG. Amplitude­integrated electroencepha­
lography (aEEG) was recorded during the first three days 
of life using cerebral function monitor­CFM Olympic 6000 
(Olympic Biomedical, USA). Mild HIE (HIE stage I) was 
defined as an altered level of consciousness that included 
irritability with periods of spontaneous eye opening and jit­
teriness, slightly abnormal muscle tone, exaggerated Moro 
and absence of autonomic dysfunction and with normal 
continuous aEEG patterns (upper margin of the trace 
>10 μV and lower margin >5 μV) and without seizures. 
Moderate HIE (HIE stage II) was defined as somnolence 
with hypotonia, weak primitive reflexes, constricted pupils, 
bradycardia or periodic breathing and moderately abnor­
mal aEEG patterns (upper margin of the trace >10 μV and 
the lower margin <5 μV) and with early seizures. Severe 
HIE (HIE stage III) was defined as stupor or coma with 
decerebrate posture, absent spontaneous activity, flaccid 
hypotonia, absent reflexes, seizures, nonreactive pupils 
and brainstem dysfunction with abnormal cranial nerve 
function and severely abnormal aEEG patterns (upper 
margin of the trace <10 μV and the lower margin <5 μV). 
A severely abnormal aEEG patterns may be accompanied 
by burst suppression or seizure activity. 
Head sonograms were performed on all neonates before 
enrolment. Lumbar puncture was indicated for neonates 
as a part of the diagnostic work­up for suspected perinatal 
HIE to rule out other intracranial disorders (e.g., congeni­
tal or acquired neonatal infections, neonatal meningitis, 
inborn errors of metabolism) that may mimic the clinical 
features of perinatal HIE. Lumbar puncture for GPX analy­
ses and NSE analyses were done in the first 72 hours of life. 
All samples were immediately frozen and stored at ­80°C 
until analysed. Hemorrhagic traumatic CSF samples were 
discarded. GPX activity in CSF was measured indirectly 
by a coupled reaction with glutathione reductase (GR) as 
determined by a modified method originally performed 
by Paglia and Valentine. The GPX activity was measured 
spectrophotometrically by GR recycling method, using an 
available commercial assay kit, according to the manufac­
turer’s instructions (Ransel test kit, Randox Laboratories 
Ltd, UK). Concentrations of NSE in CSF were measured 
using commercial NSE kit according to the manufacturer’s 
instructions (Roche Diagnostics, Mannheim, Germany).
Neurodevelopment outcome was assessed at 12 months 
of corrected gestational age by the neonatologist and the 
paediatric neurologist using the Denver Developmental 
Screening Test (DDST). Neurodevelopment outcome 
was classified as normal outcome, mild motor develop­
ment delayed (slight abnormality in muscular tone or 
mild delayed of motor development) and severe adverse 
outcome (cerebral palsy, epilepsy or if died in follow up 
period).
We excluded infants with congenital malformations, 
inherited metabolic disorders, congenital or acquired neo­
natal infections and maternal drug addiction.
All statistical analyses were performed using SPSS 
for Windows (Chicago, IL, USA). For all tests values 
of p<0.05 were considered statistically significant. Data 
were expressed as mean value with standard deviation 
or as percentages when appropriate. Group comparisons 
were performed with the Pearson χ2­test or Fisher exact 
test or Kruskall–Wallis test and Wilcoxon rank sum test. 
Correlations were calculated by the Spearman rank method. 
Receiver operating curve (ROC) was used to determine a 
cut­off point for the prediction of abnormal neurodevelop­
ment outcomes. Sensitivity, specificity and accuracy were 
then calculated.
RESULTS
We studied 90 neonates (gestational age >32 weeks) with 
perinatal asphyxia who subsequently developed HIE. 
Fifty­seven neonates had mild HIE, 24 moderate HIE, 
and 9 severe HIE. Birth weight (BW) and gestational age 
(GA) were similar among the neonates with mild, mod­
erate or severe HIE, while male and female proportions 
varied between different HIE groups (p<0.05) (Table 1). 
Distributions values of Apgar scores (AS) at 1 minute 
(W=166; p<0.05) (W=166; p<0.05) and AS at 5 minutes 
(W=181; p<0.01) and values of arterial blood cord pH 
(W=184; p<0.001), base deficit (BE) (W=167; p<0.05) and 
lactate (W=51; p<0.05) are shown in Table 1. Arterial cord 
blood pH had best predictive capacities for the severity 
of HIE and subsequent abnormal neurological outcome 
(W=916; p<0.001) (Table 1). We did not detect a significant 
difference among the values of arterial blood pH, BE and 
lactate or AS at 1 minute and AS at 5 minutes in preterm 
and term neonates.
Concentrations of NSE correlated significantly with 
the clinical severity of HIE (χ2=48.364; p<0.0001) and 37
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corresponded well with subsequent neurological outcome 
(W=65.5; p<0.0001) (Table 2). We did not detect a signifi­
cant difference in concentrations of NSE in CSF between 
preterm and term neonatal groups (Table 3). Negative lin­
ear correlation between the values of arterial cord blood pH 
and concentrations of NSE in CSF (r=­0.672; p<0.001) are 
shown in Graph 1. Elevated levels of NSE in CSF (cut off 
value for poor neurodevelopmental outcomes was found 
25.5 μg/L) were observed in all neonates with subsequent 
adverse neurological outcome (AUC of NSE in CSF: 0.942 
(0.895­0.998); p<0.001) (Graph 2).
GPX activity in CSF was significantly higher in the neo­
nates with moderate and severe HIE than in those with 
mild HIE (χ2=23.301; p<0.0001) and corresponded well 
with subsequent neurological outcome (W=179; p<0.0001) 
(Table 2). GPX activity in CSF was higher in preterm neo­
nates compared with term neonates (W=1649; p<0.0001) 
(Table 3). Negative linear correlation between values of 
arterial cord blood pH and GPX activity in CSF (r=­0.384; 
Graph 1. Negative linear correlation between arterial cord blood pH and neuron specific enolase (NSE) in cerebrospinal fluid (p<0.001)
0
10
20
30
40
50
60
70
80
90
100
6.70 6.80 6.90 7.00 7.10 7.20
N
S
E
 
(
μ
g
/
L
)
pH
ρ=-0.672; p<0.001
Table 1. Clinical and biochemical characteristic at birth in neonates with different stage of hypoxic­ischemic encephalopathy (HIE) and those with 
subsequent neurological sequels
Parameter HIE HIE stage I HIE stage II HIE stage III Neurological sequels
Gestational age (weeks) 36.6±2.6 36.4±2.5 37.4±2.6 36.2±3.1 35.8±2.7
Birth weight (g) 2711±810 2699±775 2889±796 2311±1000 2450±93
Male/Female (%) 62/38 54/46 67/33* 100/0* 67/33*
Apgar score (1st minute) 3.4±1.4 4.1±1.1 2.6±1.3 1.3±0.7* 2.5±1.6*
Apgar score (5th minute) 5.5±1.7 5.6±0.5 4.3±1.2 2.7±1.0* 3.8±1.8**
pH 7.09±0.11 7.15±0.05 7.03±0.11** 6.88±0.09*** 6.97±0.14***
Base deficit (mmol/L) ­13.1±4.2 ­11.0±1.7 ­15.5±4.5* ­19.7±3.9* ­16.5±5.1*
Lactate (mmol/L) 7.4±4.4 5.4±2.9 9.6±4.6* 13.9±3. 9* 11.0±5.1*
Numbers of neonates 90 57 24 9 15
Values are expressed as mean ± standard deviation (SD), percentages (%) or total numbers (Kruskal–Wallis chi­squared test and Wilcoxon rank sum test with 
continuity correction).
* p<0.05; ** p<0.01; *** p<0.001
Table 3. Comparison values of biochemical markers in cerebrospinal flu­
id between preterm and term neonates
Neonates Number NSE (μg/L) GPX (U/L)
Preterm 45 26.7±20.6 137.2±33.5****
Term 45 21.9±14.1 99.6±25.9
Values are expressed as mean ± SD (Fisher exact test).
**** p<0.0001
Table 2. Concentrations of biochemical markers in cerebrospinal fluid in neonates with different stage of hypoxic­ischemic encephalopathy (HIE) 
and those with subsequent neurological sequels
Parameter HIE HIE stage I HIE stage II HIE stage III Neurological sequels
NSE (μg/L) 24.3±17.7 15.4±8.2**** 33.9±16.2** 54.8±19.5*** 49.5±18.7****
GPX (U/L) 118.4±34.9 106.6±29.5**** 128.6±33.1** 166.1±27.4**** 153.7±28.7****
Values are expressed as mean ± SD (Kruskal–Wallis chi­squared test and Wilcoxon rank sum test with continuity correction).
NSE – neuron specific enolase; GPX – glutathione peroxidase
** p<0.01; *** p<0.001; **** p<0.0001
p<0.001) are shown in Graph 3. Elevated GPX activity in 
CSF (cut off value for poor neurodevelopmental outcomes 
was 123.5 U/L) was observed in all neonates with subse­
quent adverse neurological outcome (AUC of GPX in CSF: 
0.841 (0.756­0.935); p<0.001) (Graph 2). GPX activity in 
CSF showed a strong correlation with NSE levels in CSF 
(r=0.543; p<0.001) (Graph 4).
Neurodevelopment outcome at 12 months of cor­
rected gestational age corresponded well with severity 
of HIE (p<0.01) and gestation age (p<0.05) (Table 4) All 
infants with severe HIE developed severe adverse outcome 38
doi: 10.2298/SARH1202035V
Vasiljević B. et al. The Role of Oxidative Stress in Perinatal Hypoxic­Ischemic Brain Injury
Table 4. Neurodevelopment outcome in infants with different stage of hypoxic­ischemic encephalopathy (HIE) and different gestation age at birth 
(Fisher exact test)
Neurodevelopment outcome HIE HIE stage I HIE stage II HIE stage III Preterm neonates Term neonates
Normal (%) 73.9 91.3** 54.2** 0** 62.7 84.4*
Mild motor developmental delay (%) 12.5 7** 29.2** 0** 16.3* 8.9
Cerebral palsy (%) 10.2 1.7** 12.5 71.4** 14* 6.7
Epilepsy (%) 3.5 0 4.1 28.6** 13.3* 0
* p<0.05; ** p<0.01
Graph 2. Comparison of receiver operating characteristics (ROC curve) 
estimated laboratory tests
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Graph 3. Negative linear correlation between values of arterial cord blood pH and concentrations of glutathione peroxidase (GPX) in cerebrospi­
nal fluid (p<0.001)
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Graph 4. Linear correlation between concentrations neuron specific enolase (NSE) and glutathione peroxidase (GPX) in cerebrospinal fluid (p<0.001)
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(cerebral palsy, epilepsy or died in follow up period). Two 
preterm neonates with severe HIE died, one within early 
neonatal period because of multiorgan failure, the other 
died later because of respiratory dysfunction. Incidences 
of neurological sequels were significantly higher in pre­
term infants (p<0.05). NSE exhibited superior prediction 
of abnormal outcomes at 12 months of age (sensitivity was 
found 100% and specificity 81%) when compared to GPX 
activity in CSF (sensitivity was 87% and specificity 69%) 
(Graph 5).
DISCUSSION
Perinatal hypoxic­ischemic brain damage is a major cause 
of acute mortality and chronic neurological morbidity in 
infants and children [8]. The incidence of perinatal HIE 39
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varies at different gestational ages. Statistics suggest an 
incidence of HIE 3­5 per 1000 full­term births and an inci­
dence approaching 60% in premature newborns [9]. In 
our study, the incidence of perinatal HIE was similar. The 
age­dependent regional vulnerability to hypoxic­ischemic 
insults seen in the immature brain can be explained, at least 
in part, by the density of NMDA receptors and nNOS­
positive cells. The immature brain is especially sensitive 
to oxidative damage in comparison to the mature brain, 
because it has poor antioxidant capabilities and a high con­
centration of free iron and lipids. In our study males had a 
higher incidence of long term developmental disabilities 
than females. A recent analysis of a European database 
of 4500 children with cerebral palsy found that the inci­
dence of CP was 30% higher in males. Sex differences in the 
immature brain appear to be strongly influenced by intrin­
sic differences between male and female cells and that this 
is influenced by the sex chromosomes and sex hormones 
[10]. The incidence of long­term complications depends on 
the severity of HIE. Understanding of the mechanisms of 
perinatal hypoxic­ischemic brain injury is essential to the 
design of effective neuroprotective interventions [11, 12]. 
Treatment is currently limited to supportive intensive care, 
but efforts have been made to develop more effective thera­
pies. In adults, neuronal necrosis and apoptosis after global 
ischemia are slow, and last for several hours to several days. 
Studies in animals suggest a quicker cellular destruction 
and energy substrates in the neonatal brain continue to run 
down for 12 to 48 h after perinatal hypoxia [13]. Therefore, 
a neuroprotective intervention might be effective from 
6 to 8 hours after perinatal asphyxia. As neuroprotective 
interventions may be harmful, it is important to find early 
and reliable indicators of brain damage or poor long­term 
prognosis to initiate neuroprotective treatment [14].
The information obtained by examination of CSF 
is often of crucial importance in the diagnosis of many 
neurological diseases (HIE, ischemic stroke and different 
types of meningitis). Several studies measured different 
biochemical factors in serum and CSF after the hypoxic­
ischemic events [15, 16]. After irreversible cellular injury, 
brain cells die by necrotic lysis or apoptosis, which releases 
intracellular enzyme such as NSE. A high level NSE in CSF 
is considered as the result of neural damage and it could 
be a good biomarker of brain damage or dysfunction of 
CNS [17, 18]. The optimal time for measuring released 
intracellular enzyme in CSF remains uncertain. In studies 
of adults, NSE increased 18 hours to four days after cerebral 
infarction and during the first days following anoxaemia 
[19]. As delayed neuronal death peaks between the 2nd 
and 3rd day of life, the optimal time is most likely to be at 
around 72 hours. Our results provide a strong association 
between concentrations of NSE in CSF and severity of stage 
of HIE, extent of brain damage and subsequent neurologi­
cal outcome. CSF contains both powerful enzymatic and 
non­enzymatic antioxidants, and CSF analysis provides 
some important clues about the physiological or pathologi­
cal changes in the central nervous system. There is little 
information in the literature on the evaluation of oxidative 
stress markers in CSF. Our present results showed that the 
activity of GPX in CSF was markedly higher in the preterm 
neonates and neonates with severe HIE. Increased GPX 
activity in CSF occurred in response to hypoxic­ischemia 
and might suggest the overproduction of reactive oxygen 
species and brain oxidative stress. In agreement with our 
results, a gradual increase of GPX activity in CSF have 
indicated advancing stage of HIE and the extent of brain 
damage. Free radicals, which are produced continuously 
during oxidative metabolism, are generated at high rates 
within the brain. Oxidative stresses due to overproduc­
tion of free radicals effectively overwhelms the reduced 
anti­oxidative mechanisms of the newborn and have been 
suggested as possible factors contributing to the patho­
genesis of perinatal hypoxic­ischemic brain injury [20]. 
The brain contains lower superoxide dismutase, catalase 
and GPX activity compared with kidney or liver [21]. The 
neonatal brain is particularly vulnerable to oxidative dam­
age because of its high concentration of lipids, high rate 
of oxygen consumption, decreased levels of antioxidant 
enzymes (i.e. GPX and catalase) and increased availability 
of free iron [22, 23]. Oxidative injury takes place mostly 
Graph 5. Comparison of predictive value estimated laboratory tests
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during the reperfusion phase [24]. Free radicals can lead 
to lipid peroxidation as well as DNA and protein damage 
and can trigger apoptosis [25, 26]. Finally, free radicals can 
combine with nitric oxide to form peroxynitrite, a highly 
toxic oxidant. Free radicals also induce inflammation and 
further formation of more oxidative radicals during the 
reperfusion phase via non­protein bound and pro­oxidant 
enzymes, such as nitric oxide synthase, cyclooxygenase/ 
lipooxygenase, and xanthine oxidase [27]. The increased 
free radicals level causes destruction of the endothelial 
monolayer tight junctions of blood­brain barrier (BBB) 
and increases its permeability [28]. Disruption of BBB 
results in increased vascular permeability, brain oedema, 
and secondary brain damage [29]. Data associated with 
GPX activity after acute hypoxic­ischemic brain injury 
is controversial. The GPX activity in patients with acute 
hypoxic­ischemic insult was reported to be decreased, 
increased or unchanged in both CSF and serum. In our 
study, we noted increased GPX activity in CSF in neonates 
with advanced stage of HIE and lower gestation age which 
is in accordance with published data, however, we observed 
a significant correlation between the severity of stage of 
HIE and GPX activity in CSF. Increased GPX activity of 
CSF in neonates with HIE might be an indicator of perina­
tal hypoxic­ischemic brain injury and improve our ability 
to optimize the timing and assessment of neuroprotective 
treatment at the same time.
CONCLUSION
The results of our study may have clinical and research 
implications. We postulate that oxidative stress might be 
an important contributing factor in the pathogenesis of 
perinatal hypoxic­ischemic brain injury particularly in 
preterm neonates. Our results demonstrate that increased 
GPX activity in CSF is related to the extent of brain injury 
and subsequent neurological abnormalities in infants with 
perinatal HIE, which might be prevented by antioxidative 
treatment. Further experimental and clinical studies are 
needed to clarify this point.
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КРАТАК САДРжАЈ
Увод  Па то ге нет ски  ме ха ни зам  пе ри на тал ног  хи пок сич но­
ис хе мијског  оште ће ња  мо зга  је  ве о ма  сло жен.
Циљ  ра да Циљ ове сту  ди  је био је да се про  це  ни зна  чај ок­
си да тив ног стре са у на стан ку пе ри на тал ног хи пок сич но­ис­
хе мијског оште ће ња мо зга и ка сни јих не у ро ло шких се кве ла 
код но во ро ђен ча ди с хи пок сич но­ис хе мијском ен це фа ло па­
ти јом (ХИЕ). За про це ну пе ри на тал ног ок си да тив ног оште ће­
ња мо зга ко ри шће на је ин ди рект на ме то да ко јом се утвр ђу­
је ства ра ње сло бод них ра ди ка ла то ком це ре брал не хи пок­
си је, од но сно ис хе ми је ме ре њем ак тив но сти глу та тион­пе­
рок си да зе (GPX) у ли кво ру у од но су на ни во уну тар ће лиј ског 
ен зи ма не у рон­спе ци фич не ено ла зе (NSE) у ли кво ру као до­
брог  би о ло шког  по ка за те ља  оште ће ња  мо зга.
Ме то де  ра да  Про спек тив ном  сту ди јом  об у хва ће но  је  90 
но во ро ђен ча ди  (ста ри је  од  32  не де ље  ге ста ци је)  с  пе ри на­
тал  ном ХИЕ. Она је про  це  њи  ва  на на осно  ву „Сар  нат и Сар­
нат” кли нич ког ско ра и про ме на ре ги стро ва них на ен це фа­
ло гра му интегрисаних амплитуда, а потом категорисана на 
три степена. Ак тив ност GPX и кон цен тра ци ја NSE од ре ђи ва не 
су  у  ли кво ру  узе том  у  пр ва  72  ча са  по  ро ђе њу.  Не у ро ло шка 
про це на  ис пи ти ва не  де це  вр ше на  је  у  уз ра сту  од  12  ме се­
ци, а ко ри го ва на је пре ма ге ста ци о ној зре ло сти на ро ђе њу.
Ре зул та ти Ак тив ност GPX у ли кво ру је у ко ре ла ци ји с те жи­
ном  ХИЕ  и  ге ста ци о ном  зре ло шћу  но во ро ђен че та  и  у  скла­
ду  с  ка сни јим  не у ро ло шким  ис хо дом  (p<0,001).  Ак тив ност 
GPX  у  ли кво ру  је  у  јасној  ко ре ла ци ји  с  ни во ом  NSE у ли  кво­
ру (p<0,001),  која  је  до бар  по ка за те љ  интензитета  оште ће­
ња  мо зга.
За кљу чак  Ре зул та ти  ис тра жи ва ња  по ка зу ју  да  ок си да тив­
ни  стрес  има  ва жну  уло гу  у  на стан ку  пе ри на тал ног  хи пок­
сич но­ис хе мијског оште ће ња мо зга, по себ но код де те та ро­
ђе ног  пре  тер ми на.
Кључ не ре чи: хи пок сич но­ис хе мијска ен це фа ло па ти ја; глу­
та тион­пе рок си да за; не у рон­спе ци фич на ено ла за; но во ро­
ђен че;  не у ро ло шки  раз вој
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